Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS)
CNY 53.74
(0.43%)
CNY 53.74
(0.43%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 622.95 Million CNY | 51.82% |
| 2022 | 374.97 Million CNY | 4.45% |
| 2021 | 358.99 Million CNY | 8.88% |
| 2020 | 329.71 Million CNY | 66.29% |
| 2019 | 198.27 Million CNY | 29.14% |
| 2018 | 153.53 Million CNY | 8.86% |
| 2017 | 141.04 Million CNY | 2614.87% |
| 2016 | -5.6 Million CNY | -549.77% |
| 2015 | 1.24 Million CNY | 310.03% |
| 2014 | -593.7 Thousand CNY | -39.4% |
| 2013 | -425.9 Thousand CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 238.63 Million CNY | 29.08% |
| 2024 Q3 | 308.3 Million CNY | 3.32% |
| 2024 Q2 | 298.39 Million CNY | 25.04% |
| 2023 Q4 | 184.86 Million CNY | -7.46% |
| 2023 FY | 569.28 Million CNY | 51.82% |
| 2023 Q1 | 116.37 Million CNY | -31.32% |
| 2023 Q2 | 114.41 Million CNY | -1.69% |
| 2023 Q3 | 199.76 Million CNY | 74.6% |
| 2022 Q4 | 169.45 Million CNY | 164.06% |
| 2022 FY | 374.97 Million CNY | 4.45% |
| 2022 Q2 | 68.54 Million CNY | -5.84% |
| 2022 Q1 | 72.79 Million CNY | -30.77% |
| 2022 Q3 | 64.17 Million CNY | -6.38% |
| 2021 FY | 358.99 Million CNY | 8.88% |
| 2021 Q4 | 105.14 Million CNY | 31.43% |
| 2021 Q2 | 75.35 Million CNY | -23.49% |
| 2021 Q3 | 79.99 Million CNY | 6.16% |
| 2021 Q1 | 98.49 Million CNY | -5.25% |
| 2020 Q1 | 23.98 Million CNY | -55.09% |
| 2020 Q4 | 103.96 Million CNY | 11.91% |
| 2020 FY | 329.71 Million CNY | 66.29% |
| 2020 Q2 | 100.88 Million CNY | 320.56% |
| 2020 Q3 | 92.89 Million CNY | -7.92% |
| 2019 Q3 | 47.03 Million CNY | -24.44% |
| 2019 FY | 198.27 Million CNY | 29.14% |
| 2019 Q4 | 53.42 Million CNY | 13.57% |
| 2019 Q2 | 62.25 Million CNY | 75.08% |
| 2019 Q1 | 35.55 Million CNY | 86.6% |
| 2018 Q4 | 19.05 Million CNY | -44.52% |
| 2018 FY | 153.53 Million CNY | 8.86% |
| 2018 Q1 | 22.09 Million CNY | -55.43% |
| 2018 Q2 | 78.03 Million CNY | 253.11% |
| 2018 Q3 | 34.34 Million CNY | -55.98% |
| 2017 Q3 | 35.48 Million CNY | -16.91% |
| 2017 FY | 141.04 Million CNY | 2614.87% |
| 2017 Q1 | 10.39 Million CNY | 416.2% |
| 2017 Q4 | 49.57 Million CNY | 39.72% |
| 2017 Q2 | 42.7 Million CNY | 310.89% |
| 2016 Q2 | 61.46 Thousand CNY | -0.0% |
| 2016 Q4 | 2.01 Million CNY | 0.0% |
| 2016 Q3 | 2.01 Million CNY | 3175.74% |
| 2016 Q1 | 61.46 Thousand CNY | -87.6% |
| 2016 FY | -5.6 Million CNY | -549.77% |
| 2015 Q1 | 127.68 Thousand CNY | 0.0% |
| 2015 Q2 | 127.68 Thousand CNY | 0.0% |
| 2015 Q4 | 495.79 Thousand CNY | 0.0% |
| 2015 FY | 1.24 Million CNY | 310.03% |
| 2015 Q3 | 495.79 Thousand CNY | 288.3% |
| 2014 FY | -593.7 Thousand CNY | -39.4% |
| 2013 FY | -425.9 Thousand CNY | 0.0% |